What is a DaTscan and should I get one? Posted on January 8, 2019February 1, 2019 by Dr. Rebecca Gilbert What role does DaTscan have in the diagnosis of Parkinson’s disease? Many patients with Parkinson’s disease (PD) are frustrated and sometimes frankly suspicious about how it is diagnosed. As a neurologist, over the years I’ve heard comments like: “All the doctor did was have me make some movements with my hands and legs and watch […]Read More
FDA Approves Inbrija™ (levodopa inhalation powder) Parkinson’s disease Posted on December 23, 2018December 26, 2018 by Stephanie Paul FDA Approves Inbrija™ (levodopa inhalation powder) December 22, 2018 Acorda Therapeutics announced the FDA approval of INBRIJA™ (levodopa inhalation powder) for the treatment of OFF periods in people with Parkinson’s disease (PD) taking carbidopa/levodopa. INBRIJA™ is expected to be available by prescription in the first quarter of 2019, to be distributed through a network of specialty […]Read More
FDA Approves Focused Ultrasound for Tremor-predominant Parkinson’s disease Posted on December 20, 2018December 23, 2018 by Nancy Braun FDA approves focused ultrasound for tremor-predominant Parkinson’s disease December 19, 2018 Tremor-predominant Parkinson’s disease (PD) joins Essential tremor (ET) as an FDA-approved indication for the use of Focused ultrasound. Focused ultrasound is a technology in which beams of ultrasound waves are focused on a designated target thereby concentrating enough energy to create a small lesion. […]Read More
Could Coffee Protect Neurons in Parkinson’s Disease? Posted on December 14, 2018December 17, 2018 by Nancy Braun Could coffee protect neurons in Parkinson’s disease?A recently published paper reveals interesting connections between coffee and Parkinson’s disease (PD).Read More
Vascular Parkinsonism in the News Posted on December 3, 2018December 3, 2018 by Nancy Braun Vascular Parkinsonism in the NewsGeorge H.W. Bush, the 41st President of the United States died on November 30, 2018, at the age of 94.Read More
The relationship between the appendix and Parkinson’s disease Posted on November 5, 2018 by Nancy Braun The relationship between the appendix and Parkinson’s diseaseRead More
Important New Study Underway: Get Involved Posted on October 23, 2018October 23, 2018 by Nancy Braun About the “Economic Burden” StudyThe study seeks to capture more of the financial costs associated with Parkinson’s.Read More
INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS® – Parkinson’s Disease Updates Posted on October 9, 2018October 10, 2018 by Nancy Braun INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS® – Parkinson’s Disease UpdatesThe International Congress of Parkinson’s Disease and Movement Disorders is taking place this week (Oct 5-9) in Hong Kong. This is an annual meeting of Movement Disorders scientists and physicians from around the world.Read More
APDA-funded Brigham and Women’s Hospital explores the genetic variants associated with Parkinson’s disease and other conditions Posted on September 27, 2018September 27, 2018 by Nancy Braun APDA-funded Brigham and Women’s Hospital explores the genetic variants associated with Parkinson’s disease and other neuropsychiatric conditionsIn classic biochemistry, ribonucleic acid (RNA) was thought to be a simple middle man between our genome and our proteins. Recently, however, it has become clear that RNA exists in multiple forms and plays a myriad of roles, including regulating protein production, regulating genome activity, and sensing environment. In fact, only a very small portion of DNA gets transcribed into RNA that creates protein. A much large portion gets transcribed into RNA that has various other functions.Read More
FDA New Analysis on PD Psychosis Treatment Posted on September 25, 2018September 27, 2018 by Nancy Braun FDA New Analysis on PD Psychosis TreatmentOn September 20, 2018, the FDA recently released results of a new analysis finding no new or unexpected safety risks associated with Nuplazid. The new analysis was initiated because of concerns raised in the media last spring, and reassures patients that they should continue to take Nuplazid as prescribed by their physician. The FDA report highlights a number of important conceptsRead More
